Answer
It is licensed for selected adults with unresectable or metastatic urothelial cancer carrying a susceptible FGFR3 alteration after previous PD-1 or PD-L1 immunotherapy.
Sources for this answer
- Balversa 3mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.